Source: Clinical Trials Arena

AiCuris: AiCuris commences Phase I trial of AIC468 for BK virus treatment

AiCuris Anti-infective Cures has launched a first-in-human Phase I trial of AIC468, to combat BK virus (BKV) infections in KT recipients. The post AiCuris commences Phase I trial of AIC468 for BK virus treatment appeared first on Clinical Trials Arena.

Read full article »
AiCuris's Competitors | AiCuris's News | AiCuris's Financials
Stay up-to-date with the latest news on AiCuris
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Larry Edwards's photo - President & CEO of AiCuris

President & CEO

Larry Edwards

CEO Approval Rating

82/100

Read more
Stay up-to-date with the latest news on AiCuris